{"meta":{"query_hash":"a193c427e22b","filters":{"venue":"Endocrinología y Nutrición"},"cohort_total":4,"direct_labels_cover":0,"predictions_cover":4,"exported":4,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a193c427e22b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Endocrinolog%C3%ADa+y+Nutrici%C3%B3n"},"results":[{"id":"W1977652528","doi":"10.1016/j.endonu.2014.05.006","title":"Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide","year":2014,"lang":"en","type":"article","venue":"Endocrinología y Nutrición","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Immunohistochemistry; Somatostatin receptor 2; Octreotide; Cytoplasm; Expression (computer science); Somatostatin; Somatostatin Analogue; Internal medicine; Medicine; Somatostatin receptor; Endocrinology; Biology; Pathology; Cancer research; Computational biology; Cell biology; Computer science","score_opus":0.007841058294655047,"score_gpt":0.2642241410593946,"score_spread":0.2563830827647396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977652528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905274,0.0013551723,0.002468482,0.000101155296,0.000055058837,0.000030060562,0.0002892442,0.000036644582,0.00513683],"genre_scores_gemma":[0.9955701,0.00030829216,0.0012284664,0.00009960428,0.000022890486,0.00004365138,0.00051805767,0.00002521664,0.0021836779],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997384,0.00004696962,0.000025077135,0.00004705947,0.000045566558,0.00009697763],"domain_scores_gemma":[0.9997211,0.00009191741,0.0000612476,0.000042783453,0.000030363395,0.00005256205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019931346,0.0002309128,0.00038809143,0.00021705235,0.0001958946,0.0003168097,0.00016140199,0.00027653915,0.0030100471],"category_scores_gemma":[0.00041937234,0.0002589673,0.00039742637,0.00016513346,0.0005907,0.00029484186,0.0001476887,0.00041935118,0.0004557816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054709334,0.00001931521,0.0012931415,0.000034508095,0.00001520174,0.00020644939,0.000021500951,0.000023460101,0.99692094,0.000062703504,0.000034977493,0.00082072726],"study_design_scores_gemma":[0.00008064688,0.0012165098,0.12612332,0.000015482885,0.000109643865,0.0027032236,0.00026790335,0.0009163076,0.86583227,0.00015273293,0.0025656081,0.000016396958],"about_ca_topic_score_codex":0.0011030192,"about_ca_topic_score_gemma":0.002055164,"teacher_disagreement_score":0.0030100471,"about_ca_system_score_codex":0.0002513166,"about_ca_system_score_gemma":0.00023310407,"threshold_uncertainty_score":0.010069549},"labels":[],"label_agreement":null},{"id":"W2014662609","doi":"10.1016/s1575-0922(07)71519-x","title":"Nuevos tratamientos en los tumores neuroendocrinos gastroenteropancreáticos","year":2007,"lang":"es","type":"article","venue":"Endocrinología y Nutrición","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Discovery and development of mTOR inhibitors; Somatostatin; Somatostatin receptor; Oncology; Cancer research; Internal medicine; PI3K/AKT/mTOR pathway; Apoptosis; Biology","score_opus":0.014290943313252496,"score_gpt":0.3200871202165207,"score_spread":0.3057961769032682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014662609","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7066787,0.267899,0.0040548486,0.0070408965,0.0014883163,0.00010975804,0.0003253956,0.00014153594,0.0122615965],"genre_scores_gemma":[0.87753886,0.106658086,0.0036283964,0.0018440493,0.0011478371,0.000104484854,0.00049584033,0.000036862923,0.008545591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998803,0.00004054393,0.000015945016,0.000020374484,0.000021481195,0.000021367656],"domain_scores_gemma":[0.9998116,0.000085947315,0.000026415064,0.000014133115,0.000024980318,0.00003690965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029972062,0.00028304855,0.00072565343,0.000279384,0.00032010413,0.0003409682,0.00025467743,0.0003698043,0.0019828086],"category_scores_gemma":[0.0006995351,0.00008262518,0.0005255285,0.00032451845,0.00020155919,0.0003773331,0.00019507708,0.0011027593,0.00035239695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019431366,0.0020971398,0.022327509,0.0015455864,0.0005513166,0.009288176,0.00045924433,0.000983191,0.064272545,0.0010637695,0.004620775,0.8733594],"study_design_scores_gemma":[0.011055358,0.06415508,0.18489361,0.0035005389,0.0072717364,0.07600063,0.0047029895,0.004842594,0.20431232,0.006223323,0.4328538,0.000188067],"about_ca_topic_score_codex":0.0008635601,"about_ca_topic_score_gemma":0.0022022412,"teacher_disagreement_score":0.0019828086,"about_ca_system_score_codex":0.0002490679,"about_ca_system_score_gemma":0.0003082837,"threshold_uncertainty_score":0.0066331625},"labels":[],"label_agreement":null},{"id":"W2131251802","doi":"10.1016/s1575-0922(06)71071-3","title":"Evaluación de la seguridad de los catéteres de teflón en pacientes diabéticos tipo 1 tratados con infusión subcutánea continua de insulina (ISCI) mediante la determinación de la cetonemia capilar","year":2006,"lang":"es","type":"article","venue":"Endocrinología y Nutrición","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.0062872778258843826,"score_gpt":0.30713134921434754,"score_spread":0.30084407138846314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131251802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922705,0.00046077822,0.00008427359,0.000019352374,0.000008282945,0.000017509128,0.000027728322,0.0000036503343,0.00015140876],"genre_scores_gemma":[0.9988348,0.00038242622,0.00041442455,0.000035184185,0.000015896123,0.00001930926,0.000066953915,0.000002337017,0.00022867149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968255,0.00010338274,0.00004727284,0.00005906023,0.000063629726,0.00004404019],"domain_scores_gemma":[0.9988225,0.00034704094,0.00032931147,0.00006807486,0.0002538531,0.00017921386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069295726,0.0003938479,0.00096845144,0.00031910013,0.00022078671,0.00047185324,0.00015426597,0.00041397146,0.0006338116],"category_scores_gemma":[0.002500217,0.00021113796,0.00040632027,0.00035644203,0.00020140973,0.0003845279,0.00017613107,0.00050664175,0.000085575506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.209945,0.005079123,0.51702696,0.00044525618,0.0005823721,0.00079911575,0.0016693493,0.0005661669,0.11815464,0.000058730475,0.00022821565,0.14544512],"study_design_scores_gemma":[0.003606797,0.16573092,0.758619,0.00010573704,0.0018800868,0.0014181602,0.0013718433,0.0028699455,0.06231193,0.000079605146,0.0019500902,0.000055919925],"about_ca_topic_score_codex":0.0014571548,"about_ca_topic_score_gemma":0.0014131961,"teacher_disagreement_score":0.0014571548,"about_ca_system_score_codex":0.00026835618,"about_ca_system_score_gemma":0.00027879118,"threshold_uncertainty_score":0.0036647916},"labels":[],"label_agreement":null},{"id":"W2166631875","doi":"10.1016/j.endonu.2012.07.001","title":"Lorcaserin approval in the United States: Paving the way?","year":2012,"lang":"es","type":"editorial","venue":"Endocrinología y Nutrición","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Glycated hemoglobin; Medicine; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Coaching; Physical therapy; Body mass index; Gerontology; Health coaching; Family medicine; Internal medicine; Psychology; Endocrinology","score_opus":0.02599970003890066,"score_gpt":0.3142688127951977,"score_spread":0.288269112756297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166631875","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009965475,0.050815262,0.00015192521,0.11593966,0.8299181,0.000017243947,0.00007671029,0.000067792855,0.002913639],"genre_scores_gemma":[0.0008961977,0.03188382,0.00014522874,0.05787111,0.9027855,0.000018234025,0.000034519006,0.000022791182,0.0063425875],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581724,0.0011498587,0.00067727664,0.0003939449,0.0016441023,0.0003176114],"domain_scores_gemma":[0.9818413,0.008942622,0.0014958966,0.0003234002,0.005635052,0.0017617298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070080413,0.0023280093,0.0034159005,0.0021175244,0.0017260776,0.006123231,0.0023801043,0.019254409,0.007632481],"category_scores_gemma":[0.022440238,0.00083454896,0.0023694918,0.0013287055,0.0020574774,0.0040853703,0.0010409069,0.021675548,0.004771555],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008114984,0.00001789906,0.000033579472,0.00032070596,0.000030175286,0.00014587022,0.0000071890686,0.000022835398,0.000041025436,0.00032472753,0.9867411,0.0122337835],"study_design_scores_gemma":[0.00017533262,0.00007744508,0.00046559694,0.0010599828,0.00015796702,0.00048157584,0.000052463918,0.00015464937,0.00017860072,0.0010871,0.99607384,0.000035463436],"about_ca_topic_score_codex":0.0028816564,"about_ca_topic_score_gemma":0.0074850647,"teacher_disagreement_score":0.019254409,"about_ca_system_score_codex":0.0029823342,"about_ca_system_score_gemma":0.0043219686,"threshold_uncertainty_score":0.037062526},"labels":[],"label_agreement":null}]}